Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines - PubMed (original) (raw)
. 1999 Dec 3;274(49):35053-8.
doi: 10.1074/jbc.274.49.35053.
Affiliations
- PMID: 10574984
- DOI: 10.1074/jbc.274.49.35053
Free article
Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines
J N Rich et al. J Biol Chem. 1999.
Free article
Abstract
We sought to characterize the pathway by which the multifunctional cytokine transforming growth factor-beta (TGF-beta) inhibits the proliferation of normal astrocytes, and we analyzed the alterations in the TGF-beta pathway in human glioma cell lines. Upon TGF-beta treatment, primary rat astrocytes showed a significant decrease in DNA synthesis upon thymidine incorporation with a cell cycle arrest in the G(1) phase. Western analysis of the astrocytes revealed that the expression of the cyclin-dependent kinase inhibitor (CdkI) p15(INK4B) was significantly up-regulated upon TGF-beta treatment without a change in other CdkI levels. The retinoblastoma protein (Rb) became hypophosphorylated, and Cdk2 activity decreased. Analysis of Smad3 null mouse astrocytes showed a significant loss of both TGF-beta-mediated growth inhibition and p15(INK4B) induction compared with wild-type mouse astrocytes. Infection of rat astrocytes by SMAD3 and SMAD4 adenoviruses failed to induce increased expression of p15(INK4B), implying indirect transcriptional regulation of p15(INK4B) by SMAD3. High-grade human gliomas secrete TGF-beta, yet are resistant to its growth inhibitory effects. Analysis of the effects of TGF-beta on 12 human glioma cell lines showed that TGF-beta mildly inhibited the growth of six lines, had no effect on four lines, and stimulated the growth of two lines. The majority of glioma lines had homozygous deletions of the p15(INK4B) gene, except for two lines that expressed p15(INK4B) protein, which was induced further upon TGF-beta treatment. Three lines mildly induced CdkI p21(WAF1) expression in response to TGF-beta. Most tumor lines retained other TGF-beta-mediated responses, including extracellular matrix protein and angiogenic factor secretion, which may contribute to increased malignant behavior. This suggests that the loss of p15(INK4B) may explain, in part, the selective loss of growth inhibition by TGF-beta in gliomas to form a more aggressive tumor phenotype.
Similar articles
- Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-beta1-induced expression of p15/INK4B.
Frost SJ, Simpson DJ, Farrell WE. Frost SJ, et al. Mol Cell Endocrinol. 2001 May 15;176(1-2):29-37. doi: 10.1016/s0303-7207(01)00477-4. Mol Cell Endocrinol. 2001. PMID: 11369440 - TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA, Zhang D, Choo CK, Eckert RL, Jacobberger JW. Rorke EA, et al. Exp Cell Res. 2000 Aug 25;259(1):149-57. doi: 10.1006/excr.2000.4953. Exp Cell Res. 2000. PMID: 10942587 - Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH, Lin X, Derynck R. Feng XH, et al. EMBO J. 2000 Oct 2;19(19):5178-93. doi: 10.1093/emboj/19.19.5178. EMBO J. 2000. PMID: 11013220 Free PMC article. - Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.
Ravitz MJ, Wenner CE. Ravitz MJ, et al. Adv Cancer Res. 1997;71:165-207. doi: 10.1016/s0065-230x(08)60099-8. Adv Cancer Res. 1997. PMID: 9111866 Review. - Role of transforming growth factor Beta in human cancer.
Elliott RL, Blobe GC. Elliott RL, et al. J Clin Oncol. 2005 Mar 20;23(9):2078-93. doi: 10.1200/JCO.2005.02.047. J Clin Oncol. 2005. PMID: 15774796 Review.
Cited by
- TGF-β signaling: critical nexus of fibrogenesis and cancer.
Giarratana AO, Prendergast CM, Salvatore MM, Capaccione KM. Giarratana AO, et al. J Transl Med. 2024 Jun 26;22(1):594. doi: 10.1186/s12967-024-05411-4. J Transl Med. 2024. PMID: 38926762 Free PMC article. Review. - Antisense Oligonucleotides for Rapid Translation of Gene Therapy in Glioblastoma.
Desgraves JF, Mendez Valdez MJ, Chandar J, Gurses ME, Henderson L, Castro JR, Seetheram D, Ivan ME, Komotar RJ, Shah AH. Desgraves JF, et al. Cancers (Basel). 2024 May 20;16(10):1944. doi: 10.3390/cancers16101944. Cancers (Basel). 2024. PMID: 38792022 Free PMC article. Review. - TGF-β signaling in health, disease, and therapeutics.
Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, He J. Deng Z, et al. Signal Transduct Target Ther. 2024 Mar 22;9(1):61. doi: 10.1038/s41392-024-01764-w. Signal Transduct Target Ther. 2024. PMID: 38514615 Free PMC article. Review. - TGF-β Score based on Silico Analysis can Robustly Predict Prognosis and Immunological Characteristics in Lower-grade Glioma: The Evidence from Multicenter Studies.
Zhang W, Yan Z, Zhao F, He Q, Xu H. Zhang W, et al. Recent Pat Anticancer Drug Discov. 2024;19(5):610-621. doi: 10.2174/1574892819666230915143632. Recent Pat Anticancer Drug Discov. 2024. PMID: 37718518 - First Characterization of Human Dermal Fibroblasts Showing a Decreased Xylosyltransferase-I Expression Induced by the CRISPR/Cas9 System.
Fischer B, Schmidt V, Ly TD, Kleine A, Knabbe C, Faust-Hinse I. Fischer B, et al. Int J Mol Sci. 2022 May 2;23(9):5045. doi: 10.3390/ijms23095045. Int J Mol Sci. 2022. PMID: 35563435 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous